$1.4 million study will explore antioxidants' pitfalls
As free-radical-forming poisons pile up in our environment and bodies, antioxidants may ward off some of their harmful health effects.
But free radicals have a silver lining, say Cornell researchers, and too many antioxidants can do harm. With a $1.4 million grant from the NIH, they will explore why in a project that could change preventative strategies and treatments for neurodegenerative diseases like Alzheimer’s and Parkinson’s and some forms of cancer.
Starting January 1, 2014, Dr. Carolyn Sevier, assistant professor of molecular medicine at Cornell’s College of Veterinary Medicine, will use her discovery of a benefit bestowed by oxygen-derived free-radicals to launch a five-year study mapping how cells deal with oxidative stress. Like food spoils when exposed to oxygen, cells suffer oxidative stress when exposed to more reactive oxygen ions called free radicals than they can handle, which they usually manage partly with certain vitamins and minerals dubbed antioxidants.
“That’s why antioxidants are hot in the popular press and companies push things like pomegranate powder— some think consuming tons of antioxidants improves health, but that’s not necessarily true,” said Sevier. “It’s true that reducing oxidative stress can lessen cell damage. But we’re realizing that free radicals serve as useful messengers to cells, and completely quashing them can keep cells from forming their own protective defenses.”
Free radicals form in the body as products of normal metabolism, but also come from outside sources such as smoking, herbicides, pesticides, and fatty foods. Their accumulation contributes to aging, cancer, and most neurodegenerative disorders.
These unstable oxygen remnants have unpaired electrons that seek partners by taking electrons from other compounds, initiating a chain reaction of electron stealing that damages proteins and DNA. Cells usually detoxify with antioxidants and other defense mechanisms that break down or neutralize free radicals by offering a spare electron. Thus theories formed that suggested eating more antioxidants would ward off disease.
“Sadly this is an oversimplification,” said Sevier. “For every time a study has made adding extra dietary antioxidants look good, another has shown the opposite. Our study seeks to understand this dissonance. Scientists are beginning to realize now that obliterating free radicals with antioxidants can keep cells too complacent to build beneficial protective pathways free radicals normally spur. We want to identify these advantageous pathways.”
Sevier’s study will build on her previous discovery of a cellular protein that acts like a switch free radicals turn on, initiating a signaling cascade that confers cellular benefits. In the wake of the electron-stealing rampages oxidative stress sparks, proteins normally folded into compact shapes deform into unfolded messes, glomming onto other proteins in big tangles. When activated by free radicals, the protein Sevier focuses on, which is called BiP, enhances its activity as molecular chaperone, keeping proteins apart.
“This beneficial signaling pathway actually helps cells cope with oxidative stress,” said Sevier. “A drug targeting BiP in disease states could enhance its function and prevent some of the damage in disease. That may be a more selective and better strategy than just dumping in antioxidants. By finding and understanding more about the good pathways free radicals facilitate, we may find ways to improve treatments for a variety of diseases.”